Egyptian Drug Authority Promotes "Made in Egypt" Brand at Africa Health ExCon 2026
The Egyptian Drug Authority (EDA) has announced the organization of an important panel discussion as part of the "Africa Health ExCon" exhibition and conference for 2026. This session aims to discuss the future of the pharmaceutical industry in Egypt and how to transform government plans and policies into tangible production that serves citizens.
The upcoming session is titled "Made in Egypt: Transforming Policies into Pharmaceutical Production." This initiative comes as part of the Egyptian state's efforts to enhance self-sufficiency in essential medicines and medical supplies. Through this meeting, the Authority also seeks to encourage innovation and the development of technology used in local factories to meet international standards.
The "Africa Health ExCon" is considered a major platform that brings together experts, officials, and companies from various countries across the African continent. Through this participation, Egypt aims to affirm its role as a leading regional hub in the healthcare field, helping to provide high-quality medicines at affordable prices for the Egyptian market and neighboring markets.
In conclusion, the Egyptian Drug Authority invited all interested parties and specialists in the medical sector to attend this session to exchange expertise and ideas. These discussions are expected to contribute to supporting the national economy by increasing pharmaceutical exports and improving the level of health services provided to the community.